David A Largaespada, PHD - Masonic Cancer Center-Brain Tumor Program

Shadac is a program of the Robert Wood Johnson Foundation and a part of the Health Policy and Management Division of the School of Public Health at the University of Minnesota. They specialize in state and federal health policy, Medicaid and CHIP policy, delivery and payment system reform, health coverage and access to care, health care cost and affordability, health equity, social determinants, quantitative and qualitative evaluation, data analytics and visualization, state and federal surveys, and population health. Shadac provides expertise and research in these areas to inform health policy decisions and improve health outcomes. Shadac is committed to providing data-driven insights and analysis to address key health policy issues. Their team of experts conducts research, publishes reports and briefs, and presents findings on a wide range of topics, including health insurance coverage, health care access and use, health behaviors, health outcomes, health equity, and health reform strategies. They utilize various data sources, such as state and federal surveys, to evaluate the impact of health policies and inform evidence-based decision-making. Shadac's work contributes to advancing the understanding of health care systems and promoting equitable access to quality care.Generated from the website

DaVita Clinical Research, formerly known as Total Renal Research, is a clinical trial site and site management organization located in Minneapolis, Minn. It specializes in renal trials. DCR has an in-patient unit located in the Hennepin County Medical Center in downtown Minneapolis. It is part of DaVita, a California-based provider of dialysis services at more than 1,200 outpatient centers located in over 40 states and the District of Columbia. Its team of nurses and technicians use modern technology and equipment to provide its hospital partners with a comprehensive range of services, including hemodialysis, peritoneal dialysis, hemoperfusion, apheresis and continuous renal replacement therapy. DaVita also provides comprehensive patient education programs and hospital staff training.

Aria CV Inc, based in Saint Paul, MN, is pioneering a groundbreaking approach to treating pulmonary hypertension with an innovative device that operates without batteries or electronics. This elegant solution consists of four simple components: a reservoir, a balloon, a narrow conduit for gas transfer, and a nitinol anchor, all driven solely by the heartbeat. The company emphasizes its commitment to clinical investigation, as their device is currently classified as investigational and is limited to research use under U.S. Federal law. Aria CV Inc. is dedicated to advancing medical technology for improved patient outcomes. Generated from the website